Tag: U.S. Patent and Trademark Office

Inpixon Receives Notice of Allowance for U.S. Patent Covering Its Dynamic Policy System

Inpixon (NASDAQ:INPX) announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its...

Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001

Matinas BioPharma (NYSE:MTNB), a clinical-stage biopharmaceutical company, announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,058,521...

Big News Roundup: Squire Announces Samsung Electronics as Foundry Partner to Manufacture ASIC Chips; NuRAN to Provide Mobile Operators with 2G, 3G, 4G Capabilities from a Single Piece of Equipment; iLOOKABOUT Executes Sales Agreement with Lexur Appraisal to Service Montgomery County, Ohio

In case you missed it, here is this week's big news roundup in Technology.

RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-106, an Encapsulated Bowel Preparation

RedHill Biopharma (Nasdaq:RDHL) a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal diseases, today announced that it has...

Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued...

Kalytera Issues CEO Letter to Shareholders

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today issued the following letter to shareholders from the Company’s President...

Kalytera Announces Issuance of Patent Covering the Use of CBD for the Treatment of Severe and Refractory Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY. OTCQB:KALTF) announced that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Patent No. 9,889,100 B2...